Tabunda, Gemalyn .
HRN: 11-30-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
CEFUROXIME 500MG (TAB)
06/12/2023
06/19/2023
PO
500mg
BID
Thickly MSAF
Waiting Final Action